BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28103256)

  • 21. Distinguishing Tumor Cell Infiltration and Vasogenic Edema in the Peritumoral Region of Glioblastoma at the Voxel Level via Conventional MRI Sequences.
    He L; Zhang H; Li T; Yang J; Zhou Y; Wang J; Saidaer T; Liu X; Wang L; Wang Y
    Acad Radiol; 2024 Mar; 31(3):1082-1090. PubMed ID: 37689557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accurate Patient-Specific Machine Learning Models of Glioblastoma Invasion Using Transfer Learning.
    Hu LS; Yoon H; Eschbacher JM; Baxter LC; Dueck AC; Nespodzany A; Smith KA; Nakaji P; Xu Y; Wang L; Karis JP; Hawkins-Daarud AJ; Singleton KW; Jackson PR; Anderies BJ; Bendok BR; Zimmerman RS; Quarles C; Porter-Umphrey AB; Mrugala MM; Sharma A; Hoxworth JM; Sattur MG; Sanai N; Koulemberis PE; Krishna C; Mitchell JR; Wu T; Tran NL; Swanson KR; Li J
    AJNR Am J Neuroradiol; 2019 Mar; 40(3):418-425. PubMed ID: 30819771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.
    Grabowski MM; Recinos PF; Nowacki AS; Schroeder JL; Angelov L; Barnett GH; Vogelbaum MA
    J Neurosurg; 2014 Nov; 121(5):1115-23. PubMed ID: 25192475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereotactic biopsy and resection of thalamic astrocytomas.
    Kelly PJ
    Neurosurgery; 1989 Aug; 25(2):185-94; discussion 194-5. PubMed ID: 2549442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitotic Activity in Glioblastoma Correlates with Estimated Extravascular Extracellular Space Derived from Dynamic Contrast-Enhanced MR Imaging.
    Mills SJ; du Plessis D; Pal P; Thompson G; Buonacorrsi G; Soh C; Parker GJ; Jackson A
    AJNR Am J Neuroradiol; 2016 May; 37(5):811-7. PubMed ID: 26705318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
    Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
    J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MRI-localized biopsies reveal subtype-specific differences in molecular and cellular composition at the margins of glioblastoma.
    Gill BJ; Pisapia DJ; Malone HR; Goldstein H; Lei L; Sonabend A; Yun J; Samanamud J; Sims JS; Banu M; Dovas A; Teich AF; Sheth SA; McKhann GM; Sisti MB; Bruce JN; Sims PA; Canoll P
    Proc Natl Acad Sci U S A; 2014 Aug; 111(34):12550-5. PubMed ID: 25114226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of post-contrast T1-weighted MRI surface regularity, tumor bulk, and necrotic volume with Ki67 and p53 in glioblastomas.
    Hasse A; Dapash M; Jeong Y; Ansari SA; Carroll TJ; Lesniak M; Ginat DT
    Neuroradiology; 2019 Aug; 61(8):861-867. PubMed ID: 31020343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Peritumoral Brain Parenchyma Using Contrast-Enhanced 3D Fast Imaging Employing Steady-State Acquisition at 3T for Differentiating Metastatic Brain Tumors and Glioblastomas.
    Yamamoto J; Kakeda S; Shimajiri S; Nakano Y; Saito T; Ide S; Moriya J; Korogi Y; Nishizawa S
    World Neurosurg; 2018 Dec; 120():e719-e729. PubMed ID: 30165229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative Delta T1 (dT1) as a Replacement for Adjudicated Central Reader Analysis of Contrast-Enhancing Tumor Burden: A Subanalysis of the American College of Radiology Imaging Network 6677/Radiation Therapy Oncology Group 0625 Multicenter Brain Tumor Trial.
    Schmainda KM; Prah MA; Zhang Z; Snyder BS; Rand SD; Jensen TR; Barboriak DP; Boxerman JL
    AJNR Am J Neuroradiol; 2019 Jul; 40(7):1132-1139. PubMed ID: 31248863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. pH-Weighted amine chemical exchange saturation transfer echo planar imaging visualizes infiltrating glioblastoma cells.
    Patel KS; Yao J; Cho NS; Sanvito F; Tessema K; Alvarado A; Dudley L; Rodriguez F; Everson R; Cloughesy TF; Salamon N; Liau LM; Kornblum HI; Ellingson BM
    Neuro Oncol; 2024 Jan; 26(1):115-126. PubMed ID: 37591790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peritumoral brain regions in gliomas and meningiomas: investigation with isotropic diffusion-weighted MR imaging and diffusion-tensor MR imaging.
    Provenzale JM; McGraw P; Mhatre P; Guo AC; Delong D
    Radiology; 2004 Aug; 232(2):451-60. PubMed ID: 15215555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging of Primary Brain Tumors and Metastases with Fast Quantitative 3-Dimensional Magnetization Transfer.
    Garcia M; Gloor M; Bieri O; Radue EW; Lieb JM; Cordier D; Stippich C
    J Neuroimaging; 2015; 25(6):1007-14. PubMed ID: 25702714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency and Evolution of New Postoperative Enhancement on 3 Tesla Intraoperative and Early Postoperative Magnetic Resonance Imaging.
    Miskin N; Unadkat P; Carlton ME; Golby AJ; Young GS; Huang RY
    Neurosurgery; 2020 Aug; 87(2):238-246. PubMed ID: 31584071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Volumetric assessment of glioblastoma and its predictive value for survival.
    Henker C; Hiepel MC; Kriesen T; Scherer M; Glass Ä; Herold-Mende C; Bendszus M; Langner S; Weber MA; Schneider B; Unterberg A; Piek J
    Acta Neurochir (Wien); 2019 Aug; 161(8):1723-1732. PubMed ID: 31254065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in proliferating cell nuclear antigen expression in glioblastoma multiforme cells along a stereotactic biopsy trajectory.
    Dalrymple SJ; Parisi JE; Roche PC; Ziesmer SC; Scheithauer BW; Kelly PJ
    Neurosurgery; 1994 Dec; 35(6):1036-44; discussion 1044-5. PubMed ID: 7885547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-Parametric MRI and Texture Analysis to Visualize Spatial Histologic Heterogeneity and Tumor Extent in Glioblastoma.
    Hu LS; Ning S; Eschbacher JM; Gaw N; Dueck AC; Smith KA; Nakaji P; Plasencia J; Ranjbar S; Price SJ; Tran N; Loftus J; Jenkins R; O'Neill BP; Elmquist W; Baxter LC; Gao F; Frakes D; Karis JP; Zwart C; Swanson KR; Sarkaria J; Wu T; Mitchell JR; Li J
    PLoS One; 2015; 10(11):e0141506. PubMed ID: 26599106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraoperative tissue fluorescence using 5-aminolevolinic acid (5-ALA) is more sensitive than contrast MRI or amino acid positron emission tomography ((18)F-FET PET) in glioblastoma surgery.
    Roessler K; Becherer A; Donat M; Cejna M; Zachenhofer I
    Neurol Res; 2012 Apr; 34(3):314-7. PubMed ID: 22449387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of immunohistologic and perfusion vascular parameters with MR contrast enhancement using image-guided biopsy specimens in gliomas.
    Jain R; Narang J; Gutierrez J; Schultz LR; Scarpace L; Rosenblum M; Mikkelsen T; Rock JP
    Acad Radiol; 2011 Aug; 18(8):955-62. PubMed ID: 21718954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microrecording and image-guided stereotactic biopsy of deep-seated brain tumors.
    Iijima K; Hirato M; Miyagishima T; Horiguchi K; Sugawara K; Hirato J; Yokoo H; Yoshimoto Y
    J Neurosurg; 2015 Oct; 123(4):978-88. PubMed ID: 25816085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.